Article
CCR5 mediates rheumatoid arthritis progression by promoting the activation and proliferation of non-classical Th1 cells.
International journal of rheumatic diseases - 1 Nov 2024
Miao Jinlin, Zhang Bei, Sun Haoyang, Zhang Peiyan, Shen Haomiao, Wang Jiawei, Jia Junfeng, Zhang Kui, Zheng Zhaohui, Zhu Ping
Abstract excerpt
AIM: Rheumatoid arthritis (RA) is a prevalent autoimmune disease characterized by immune dysegulation, including an immune imbalance due to abnormal activation of non-classical Th1 cells (CD161+ Th1). This study investigated the effects of CCR5 on the activation and proliferation of CD161+ Th1 and their pathogenicity in patients with RA. METHODS: The study was conducted on 53 patients with RA and 32 age- and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
